Cargando…
Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years
In order to provide comprehensive information on the differences in bioactivity between human insulin and insulin analogues, published in vitro comparisons of human insulin and the rapid acting analogues insulin lispro (Humalog(®)), insulin aspart ( NovoRapid(®)), insulin glulisine (Apidra(®)), and...
Autores principales: | Werner, Haim, Chantelau, Ernst A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160352/ https://www.ncbi.nlm.nih.gov/pubmed/21714872 http://dx.doi.org/10.1186/1758-5996-3-13 |
Ejemplares similares
-
Meeting Report: 3(rd )International Workshop on Insulin & Cancer Heidelberg, Germany, October 30-31, 2010
por: Chantelau, Ernst, et al.
Publicado: (2010) -
Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010) -
Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report
por: Chantelau, Ernst A, et al.
Publicado: (2014) -
Characterisation of insulin analogues therapeutically available to patients
por: Adams, Gary G., et al.
Publicado: (2018) -
The metabolic and mitogenic properties of basal insulin analogues
por: Tennagels, Norbert, et al.
Publicado: (2013)